NEW YORK, March 6 – Rosetta Inpharmatics has released Version 2.0 of its Rosetta Resolver gene expression data analysis system, the company announced Tuesday.

The chief improvement this update offers over Version 1.6, the last update released in October, is an improved ability to analyze data from single-color intensity-based DNA chips, the company said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.